Status:
COMPLETED
Non -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and Dexamethasone
Lead Sponsor:
iOMEDICO AG
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Brief Summary
Purpose of this non-interventional study is the documentation of efficacy and safety data of multiple myeloma therapy with a combined treatment of Lenalidomide and Dexamethasone in daily routine pract...
Eligibility Criteria
Inclusion
- Patients with multiple myeloma with at least one previous therapy.
- 18 years or older
- Signed, written informed consent
Exclusion
- Pregnancy or nursing
- All other exclusion criteria listed in SmPC (summary of product characteristics)
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT00911105
Start Date
May 1 2009
End Date
November 1 2015
Last Update
June 6 2018
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Onkologische Schwerpunktpraxis
Bad Homburg, Germany, 61348
2
Onkologische Schwerpunktpraxis
Berlin, Germany, 10365
3
Onkologisches Versorgungszentrum Friedrichshain
Berlin, Germany, 10407
4
Onkologische Praxis
Berlin, Germany, 13439